Blog
These blog posts explore GP2’s work in further understanding the genetic architecture of Parkinson’s disease.
GP2 and AMP PD: Platform Partners for Progress in Parkinson’s Research
Learn MoreAdding a layer of compute to connect two massive datasets is where we are headed. Mike Nalls, Hampton Leonard, Matt Bookman, and Eline Appelmans outline the pa…
What is Compliance and Why is it Important?
By GP2 Operations and Compliance Working Group | Research Operations |Learn MoreMembers of the GP2 Operations and Compliance working group provide an overview of what compliance is and why it is important in GP2.
Understanding GWAS
By GP2 Complex Disease Data Analysis Working Group | Complex Disease Genetics |Learn MoreMembers of the GP2 Complex Disease Data Analysis working group provide an overview of Genome-Wide Association Studies (GWAS), including statistical formulae, w…
Parkinson’s Disease Genetics: Cause, Risk, or Protection?
By Christine Klein | Monogenic Disease Genetics |Learn MoreChristine Klein leads the GP2 Monogenic Hub. In this post Christine shares how her interest in Parkinson’s disease genetics was sparked, which genes have been …
Decoding the Aliens Within
Learn MoreGP2 aims to identify novel disease-causing genes and mutations. Benjamin Stecher outlines his hopes for GP2, as we delve into the unknown and build a foundatio…
Open Science Opens Doors
By Bradford Casey | GP2 Values |Learn MoreIn GP2, underlying data, analytical processes, and results will be made available to the research community as quickly as possible, with minimal barriers to ac…